{"id":"39404160-eb41-500c-a85f-94976fc1be61","stable_key":"3238e4f0-8d45-5c72-8624-6e9a8b20527c:ibu-blocks-entry-not-orientation","predicate":"inhibits","statement":"Native ovine cyclooxygenase-1 produced primarily prostaglandin G2 along with 11R-, 15S- and 15R-hydroxyeicosatetraenoic acids with different Km values for each product, establishing that arachidonate can assume at least three catalytically productive arrangements within the site, and half-maximal inhibitory concentrations for the competitive inhibitor ibuprofen were the same for every product of a given enzyme form, 175 micromolar for the native enzyme and 15 micromolar for the V349L mutant, most simply rationalised by a model in which arachidonate forms its various arrangements only after entering the cyclooxygenase active site.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"dd935add-5ea1-55d6-a923-2c07614d3a60","mechanism_event_label":"The drug blocks the door rather than any one position inside, which is why it stops every product equally.","subject":{"id":"b429f269-1d01-59f4-881a-868de0849d0d","slug":"ibuprofen","display_name":"Ibuprofen","entity_type_key":"drug"},"object":{"id":"aeb054c7-58c1-5075-8937-9c7b22c20383","slug":"cox-product-profile","display_name":"The profile of prostaglandin G2 and monohydroxy acid products of cyclooxygenase","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"dd935add-5ea1-55d6-a923-2c07614d3a60","stable_key":"3238e4f0-8d45-5c72-8624-6e9a8b20527c:ibu-blocks-entry-not-orientation-event","event_type":"biochemical_relationship","label":"The drug blocks the door rather than any one position inside, which is why it stops every product equally.","description":"Native ovine cyclooxygenase-1 produced primarily prostaglandin G2 along with 11R-, 15S- and 15R-hydroxyeicosatetraenoic acids with different Km values for each product, establishing that arachidonate can assume at least three catalytically productive arrangements within the site, and half-maximal inhibitory concentrations for the competitive inhibitor ibuprofen were the same for every product of a given enzyme form, 175 micromolar for the native enzyme and 15 micromolar for the V349L mutant, most simply rationalised by a model in which arachidonate forms its various arrangements only after entering the cyclooxygenase active site.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"39f9446f-52a6-502d-b507-91137726f82c","slug":"arachidonic-acid","display_name":"AA","entity_type_key":"small_molecule"},"role":"displaced_substrate","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"3a693286-2f97-5bfc-a1d6-986ec4694029","slug":"reversible-cox-inhibition","display_name":"Reversible, competitive inhibition of cyclooxygenase","entity_type_key":"cellular_process"},"role":"mechanism","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"b429f269-1d01-59f4-881a-868de0849d0d","slug":"ibuprofen","display_name":"Ibuprofen","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"aeb054c7-58c1-5075-8937-9c7b22c20383","slug":"cox-product-profile","display_name":"The profile of prostaglandin G2 and monohydroxy acid products of cyclooxygenase","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/ibuprofen-research/10722687.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"8e9ebedd8a4d791246c951376fa2f6f07a5ca8af828bafd15836bec26c090348\", \"start_char\": 0, \"end_char\": 2063, \"text_sha256\": \"8e9ebedd8a4d791246c951376fa2f6f07a5ca8af828bafd15836bec26c090348\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Product analysis and kinetics for solubilised, membrane-associated and active-site-mutant ovine cyclooxygenase-1","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Arachidonate product profiling with ibuprofen as a competitive inhibitor","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The identical inhibitory concentration across three different products is the informative result. The concentrations are high and the enzyme is ovine.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers.","comparator":null,"unit":null,"notes":"","entity":{"slug":"ibuprofen","display_name":"Ibuprofen","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Sheep enzyme","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The drug blocks the door rather than any one position inside, which is why it stops every product equally.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[ibu-p10722687] Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. (2000). https://pubmed.ncbi.nlm.nih.gov/10722687/ DOI: 10.1074/jbc.275.12.8501","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cyclooxygenase-1","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"adf6bc8e-c0e7-5d87-92f6-ff784588bb41","evidence_kind":"source_excerpt","locator":"Lines 305-316","start_line":305,"end_line":316,"excerpt":"### ibu-blocks-entry-not-orientation\nNative ovine cyclooxygenase-1 produced primarily prostaglandin G2 along with 11R-, 15S- and 15R-hydroxyeicosatetraenoic acids with different Km values for each product, establishing that arachidonate can assume at least three catalytically productive arrangements within the site, and half-maximal inhibitory concentrations for the competitive inhibitor ibuprofen were the same for every product of a given enzyme form, 175 micromolar for the native enzyme and 15 micromolar for the V349L mutant, most simply rationalised by a model in which arachidonate forms its various arrangements only after entering the cyclooxygenase active site.\nCondition category: normal\nnutrient_topic: Ibuprofen research collection; topical membership is not evidence of a direct clinical effect, and the racemate is recorded separately from each of its two enantiomers.\nplain_language: The drug blocks the door rather than any one position inside, which is why it stops every product equally.\norganism: Sheep enzyme\ntissue_or_cell_type: Cyclooxygenase-1\nexperimental_model: Product analysis and kinetics for solubilised, membrane-associated and active-site-mutant ovine cyclooxygenase-1\nlimitations: The identical inhibitory concentration across three different products is the informative result. The concentrations are high and the enzyme is ovine.\nexposure: Arachidonate product profiling with ibuprofen as a competitive inhibitor\nevidence_span: {\"source_cache\": \"artifacts/ibuprofen-research/10722687.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"8e9ebedd8a4d791246c951376fa2f6f07a5ca8af828bafd15836bec26c090348\", \"start_char\": 0, \"end_char\": 2063, \"text_sha256\": \"8e9ebedd8a4d791246c951376fa2f6f07a5ca8af828bafd15836bec26c090348\"}\n[ibu-p10722687] Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. (2000). https://pubmed.ncbi.nlm.nih.gov/10722687/ DOI: 10.1074/jbc.275.12.8501","model_system":"Product analysis and kinetics for solubilised, membrane-associated and active-site-mutant ovine cyclooxygenase-1","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [ibu-p10722687] Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products. (2000). https://pubmed.ncbi.nlm.nih.gov/10722687/ DOI: 10.1074/jbc.275.12.8501","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"31c4939d-f520-55c0-973b-224743caf245","stable_key":"import-3238e4f0-8d45-5c72-8624-6e9a8b20527c","title":"Ibuprofen: the enantiomer that works, the one that was called inactive, the one-way chemistry that turns one into the other, and the targets that are not cyclooxygenase (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"cc2b388178f97f5906b66ecbe441fc5c86d51fd645947c5260fb0b4bdb4bcd21","revision_id":"0b4e5c65-05d3-5430-a4cd-8d6a03647dcb","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}